{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:47:55Z","timestamp":1792198075554,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and remains refractory to current therapies. Beyond profound immunosuppression, GBM is characterized by a complex tumor microenvironment (TME) in which neutrophils have emerged as critical yet understudied regulators of tumor progression and immune evasion. Tumor-associated neutrophils (TANs) display marked functional plasticity, acquiring pro-tumor or anti-tumor phenotypes depending on microenvironmental cues. GBM recruits and reprograms infiltrating neutrophils through chemokine-driven trafficking, hypoxia, and tumor-derived cytokines, promoting angiogenesis, glioma stem-like cell support, and immune suppression via vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 release (MMP-9), arginase-1, and neutrophil extracellular traps (NETs). Conversely, under inflammatory or therapeutically modulated conditions, neutrophils can exert cytotoxic and antibody-dependent anti-tumor functions and enhance T-cell responses. Clinically, elevated neutrophil-to-lymphocyte ratios and intratumoral neutrophil transcriptional signatures correlate with poor prognosis and resistance to immunotherapy. Emerging therapeutic strategies aim to modulate neutrophil recruitment, metabolism, polarization, and NET formation, often in combination with immune checkpoint blockade. This review synthesizes current knowledge of neutrophil biology in GBM, highlights their dualistic roles within the TME, and outlines translational opportunities for neutrophil-targeted therapies.<\/jats:p>","DOI":"10.1007\/s11033-026-11525-3","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:38:00Z","timestamp":1770104280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neutrophils in glioblastoma: orchestrators of the tumor microenvironment and immune evasion"],"prefix":"10.1007","volume":"53","author":[{"given":"Enes","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rahmanipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zeinali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Karsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"11525_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1055\/s-0042-1742333","volume":"11","author":"MR Owens","year":"2022","unstructured":"Owens MR, Nguyen S, Karsy M (2022) Utility of administrative databases and big data on Understanding glioma Treatment\u2014A systematic review. Indian J Neurosurg 11:104\u2013117. https:\/\/doi.org\/10.1055\/s-0042-1742333","journal-title":"Indian J Neurosurg"},{"issue":"7","key":"11525_CR2","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1158\/0008-5472.CAN-23-2557","volume":"84","author":"HR Underhill","year":"2024","unstructured":"Underhill HR, Karsy M, Davidson CJ, Hellwig S, Stevenson S, Goold EA et al (2024) Subclonal cancer driver mutations are prevalent in the unresected peritumoral edema of adult diffuse gliomas. Cancer Res 84(7):1149\u20131164. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2557","journal-title":"Cancer Res"},{"issue":"7","key":"11525_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK (2023) Glioblastoma and other primary brain malignancies in adults: A review. JAMA 329(7):574\u2013587. https:\/\/doi.org\/10.1001\/jama.2023.0023","journal-title":"JAMA"},{"issue":"1","key":"11525_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-024-03222-4","volume":"21","author":"J Wen","year":"2024","unstructured":"Wen J, Liu D, Zhu H, Shu K (2024) Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy. J Neuroinflammation 21(1):226. https:\/\/doi.org\/10.1186\/s12974-024-03222-4","journal-title":"J Neuroinflammation"},{"key":"11525_CR5","doi-asserted-by":"publisher","first-page":"927233","DOI":"10.3389\/fimmu.2022.927233","volume":"13","author":"G Wang","year":"2022","unstructured":"Wang G, Wang J, Niu C, Zhao Y, Wu P (2022) Neutrophils: new critical regulators of glioma. Front Immunol 13:927233. https:\/\/doi.org\/10.3389\/fimmu.2022.927233","journal-title":"Front Immunol"},{"issue":"1","key":"11525_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12885-022-10492-9","volume":"23","author":"X Wang","year":"2023","unstructured":"Wang X, Li X, Wu Y, Hong J, Zhang M (2023) The prognostic significance of tumor-associated neutrophils and Circulating neutrophils in glioblastoma (WHO CNS5 classification). BMC Cancer 23(1):20. https:\/\/doi.org\/10.1186\/s12885-022-10492-9","journal-title":"BMC Cancer"},{"issue":"2","key":"11525_CR7","doi-asserted-by":"publisher","first-page":"e1075693","DOI":"10.1080\/2162402X.2015.1075693","volume":"5","author":"A Rahbar","year":"2016","unstructured":"Rahbar A, Cederarv M, Wolmer-Solberg N, Tammik C, Stragliotto G, Peredo I et al (2016) Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients. Oncoimmunology 5(2):e1075693. https:\/\/doi.org\/10.1080\/2162402X.2015.1075693","journal-title":"Oncoimmunology"},{"key":"11525_CR8","doi-asserted-by":"publisher","first-page":"1393173","DOI":"10.3389\/fimmu.2024.1393173","volume":"15","author":"C Sun","year":"2024","unstructured":"Sun C, Wang S, Ma Z, Zhou J, Ding Z, Yuan G et al (2024) Neutrophils in glioma microenvironment: from immune function to immunotherapy. Front Immunol 15:1393173. https:\/\/doi.org\/10.3389\/fimmu.2024.1393173","journal-title":"Front Immunol"},{"key":"11525_CR9","doi-asserted-by":"publisher","first-page":"1183465","DOI":"10.3389\/fimmu.2023.1183465","volume":"14","author":"DS Rubenich","year":"2023","unstructured":"Rubenich DS, de Souza PO, Omizzollo N, Aubin MR, Basso PJ, Silva LM et al (2023) Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression. Front Immunol 14:1183465. https:\/\/doi.org\/10.3389\/fimmu.2023.1183465","journal-title":"Front Immunol"},{"issue":"1","key":"11525_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12885-025-14118-8","volume":"25","author":"MW Chung","year":"2025","unstructured":"Chung MW, Tzeng CC, Huang YC, Wei KC, Hsu PW, Chuang CC et al (2025) Neutrophil-to-lymphocyte ratio dynamics: prognostic value and potential for surveilling glioblastoma recurrence. BMC Cancer 25(1):709. https:\/\/doi.org\/10.1186\/s12885-025-14118-8","journal-title":"BMC Cancer"},{"issue":"3","key":"11525_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L et al (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell 16(3):183\u2013194. https:\/\/doi.org\/10.1016\/j.ccr.2009.06.017","journal-title":"Cancer Cell"},{"issue":"3","key":"11525_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.critrevonc.2011.06.004","volume":"82","author":"H Piccard","year":"2012","unstructured":"Piccard H, Muschel RJ, Opdenakker G (2012) On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol 82(3):296\u2013309. https:\/\/doi.org\/10.1016\/j.critrevonc.2011.06.004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"11525_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2567.2008.02950.x","volume":"125","author":"RC Furze","year":"2008","unstructured":"Furze RC, Rankin SM (2008) Neutrophil mobilization and clearance in the bone marrow. Immunology 125(3):281\u2013288. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02950.x","journal-title":"Immunology"},{"issue":"9","key":"11525_CR14","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.ccell.2024.08.008","volume":"42","author":"M Lad","year":"2024","unstructured":"Lad M, Beniwal AS, Jain S, Shukla P, Kalistratova V, Jung J et al (2024) Glioblastoma induces the recruitment and differentiation of dendritic-like hybrid neutrophils from skull bone marrow. Cancer Cell 42(9):1549\u201369e16. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.008","journal-title":"Cancer Cell"},{"key":"11525_CR15","doi-asserted-by":"publisher","unstructured":"Cugurra A, Mamuladze T, Rustenhoven J, Dykstra T, Beroshvili G, Greenberg ZJ et al (2021) Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science 373(6553) https:\/\/doi.org\/10.1126\/science.abf7844","DOI":"10.1126\/science.abf7844"},{"issue":"9","key":"11525_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41593-018-0213-2","volume":"21","author":"F Herisson","year":"2018","unstructured":"Herisson F, Frodermann V, Courties G, Rohde D, Sun Y, Vandoorne K et al (2018) Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat Neurosci 21(9):1209\u20131217. https:\/\/doi.org\/10.1038\/s41593-018-0213-2","journal-title":"Nat Neurosci"},{"issue":"1","key":"11525_CR17","doi-asserted-by":"publisher","first-page":"14142","DOI":"10.1038\/s41598-024-64780-4","volume":"14","author":"S Shao","year":"2024","unstructured":"Shao S, Delk NA, Jones CN (2024) A microphysiological system reveals neutrophil contact-dependent Attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy. Sci Rep 14(1):14142. https:\/\/doi.org\/10.1038\/s41598-024-64780-4","journal-title":"Sci Rep"},{"issue":"6","key":"11525_CR18","doi-asserted-by":"publisher","first-page":"e70368","DOI":"10.1002\/ctm2.70368","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang K, Li J, Wang C, Li P, Du L (2025) Neutrophil extracellular traps in cancer: from mechanisms to treatments. Clin Transl Med 15(6):e70368. https:\/\/doi.org\/10.1002\/ctm2.70368","journal-title":"Clin Transl Med"},{"issue":"1","key":"11525_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-024-01244-9","volume":"22","author":"L Koenderman","year":"2025","unstructured":"Koenderman L, Vrisekoop N (2025) Neutrophils in cancer: from biology to therapy. Cell Mol Immunol 22(1):4\u201323. https:\/\/doi.org\/10.1038\/s41423-024-01244-9","journal-title":"Cell Mol Immunol"},{"key":"11525_CR20","doi-asserted-by":"publisher","unstructured":"Demir E, Montgomery D, Saloum A, Yaghi NK, Karsy M (2025) Current Understanding regarding the glioma microenvironment and impact of the immune system. Neuroglia 6(13) https:\/\/doi.org\/10.3390\/neuroglia6010013","DOI":"10.3390\/neuroglia6010013"},{"issue":"20","key":"11525_CR21","doi-asserted-by":"publisher","first-page":"eadj3301","DOI":"10.1126\/sciadv.adj3301","volume":"10","author":"MJ Haley","year":"2024","unstructured":"Haley MJ, Bere L, Minshull J, Georgaka S, Garcia-Martin N, Howell G et al (2024) Hypoxia coordinates the Spatial landscape of myeloid cells within glioblastoma to affect survival. Sci Adv 10(20):eadj3301. https:\/\/doi.org\/10.1126\/sciadv.adj3301","journal-title":"Sci Adv"},{"issue":"1","key":"11525_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","volume":"13","author":"N Abdelfattah","year":"2022","unstructured":"Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R et al (2022) Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun 13(1):767. https:\/\/doi.org\/10.1038\/s41467-022-28372-y","journal-title":"Nat Commun"},{"key":"11525_CR23","doi-asserted-by":"publisher","unstructured":"Friedmann-Morvinski D, Hambardzumyan D (2023) Monocyte-neutrophil entanglement in glioblastoma. J Clin Invest 133(1) https:\/\/doi.org\/10.1172\/JCI163451","DOI":"10.1172\/JCI163451"},{"issue":"5","key":"11525_CR24","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.immuni.2025.03.021","volume":"58","author":"F Galvez-Cancino","year":"2025","unstructured":"Galvez-Cancino F, Navarrete M, Beattie G, Puccio S, Conde-Gallastegi E, Foster K et al (2025) Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies. Immunity 58(5):1236\u201353e8. https:\/\/doi.org\/10.1016\/j.immuni.2025.03.021","journal-title":"Immunity"},{"key":"11525_CR25","doi-asserted-by":"publisher","unstructured":"Maas RR, Soukup K, Fournier N, Massara M, Galland S, Kornete M et al (2023) The local microenvironment drives activation of neutrophils in human brain tumors. Cell 186(21):4546\u20134566. https:\/\/doi.org\/10.1016\/j.cell.2023.08.043","DOI":"10.1016\/j.cell.2023.08.043"},{"issue":"3","key":"11525_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA (2017) The microenvironmental landscape of brain tumors. Cancer Cell 31(3):326\u2013341. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.009","journal-title":"Cancer Cell"},{"key":"11525_CR27","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.smim.2021.101582","volume":"57","author":"ME Shaul","year":"2021","unstructured":"Shaul ME, Fridlender ZG (2021) The dual role of neutrophils in cancer. Semin Immunol 57:101582. https:\/\/doi.org\/10.1016\/j.smim.2021.101582","journal-title":"Semin Immunol"},{"issue":"15","key":"11525_CR28","doi-asserted-by":"publisher","first-page":"15290","DOI":"10.18632\/aging.103428","volume":"12","author":"PF Wang","year":"2020","unstructured":"Wang PF, Zhang YX, Su J, Yao K, Li SW, Huang GR et al (2020) Neutrophil depletion enhances the therapeutic effect of PD-1 antibody on glioma. Aging 12(15):15290\u201315301. https:\/\/doi.org\/10.18632\/aging.103428","journal-title":"Aging"},{"issue":"9","key":"11525_CR29","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/neuonc\/now034","volume":"18","author":"PR Gielen","year":"2016","unstructured":"Gielen PR, Schulte BM, Kers-Rebel ED, Verrijp K, Bossman SA, Ter Laan M et al (2016) Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8\/9 and arginase and suppress T cell function. Neuro Oncol 18(9):1253\u20131264. https:\/\/doi.org\/10.1093\/neuonc\/now034","journal-title":"Neuro Oncol"},{"issue":"6","key":"11525_CR30","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/2159-8290.CD-24-1056","volume":"15","author":"A Ugolini","year":"2025","unstructured":"Ugolini A, De Leo A, Yu X, Scirocchi F, Liu X, Peixoto B et al (2025) Functional reprogramming of neutrophils within the brain tumor microenvironment by Hypoxia-Driven histone lactylation. Cancer Discov 15(6):1270\u20131296. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-1056","journal-title":"Cancer Discov"},{"issue":"1","key":"11525_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41389-022-00398-3","volume":"11","author":"H Raskov","year":"2022","unstructured":"Raskov H, Orhan A, Gaggar S, Gogenur I (2022) Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy. Oncogenesis 11(1):22. https:\/\/doi.org\/10.1038\/s41389-022-00398-3","journal-title":"Oncogenesis"},{"issue":"1","key":"11525_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/1078-0432.CCR-13-1279","volume":"20","author":"J Liang","year":"2014","unstructured":"Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N et al (2014) Neutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res 20(1):187\u2013198. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1279","journal-title":"Clin Cancer Res"},{"issue":"1","key":"11525_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.20892\/j.issn.2095-3941.2019.0353","volume":"17","author":"C Zha","year":"2020","unstructured":"Zha C, Meng X, Li L, Mi S, Qian D, Li Z et al (2020) Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1\/RAGE\/IL-8 axis. Cancer Biol Med 17(1):154\u2013168. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2019.0353","journal-title":"Cancer Biol Med"},{"issue":"19","key":"11525_CR34","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1158\/0008-5472.CAN-21-4045","volume":"82","author":"H Deng","year":"2022","unstructured":"Deng H, Lin C, Garcia-Gerique L, Fu S, Cruz Z, Bonner EE et al (2022) A novel selective inhibitor JBI-589 targets PAD4-Mediated neutrophil migration to suppress tumor progression. Cancer Res 82(19):3561\u20133572. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4045","journal-title":"Cancer Res"},{"key":"11525_CR35","doi-asserted-by":"publisher","first-page":"103372","DOI":"10.1016\/j.critrevonc.2021.103372","volume":"163","author":"A Gomes Dos Santos","year":"2021","unstructured":"Gomes Dos Santos A, de Carvalho RF, de Morais A, Silva TM, Baylao VMR, Azevedo M et al (2021) Role of neutrophil-lymphocyte ratio as a predictive factor of glioma tumor grade: A systematic review. Crit Rev Oncol Hematol 163:103372. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103372","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"11525_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11060-013-1164-9","volume":"114","author":"RM Bambury","year":"2013","unstructured":"Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE et al (2013) The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol 114(1):149\u2013154. https:\/\/doi.org\/10.1007\/s11060-013-1164-9","journal-title":"J Neurooncol"},{"issue":"3","key":"11525_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11060-017-2395-y","volume":"132","author":"M Mason","year":"2017","unstructured":"Mason M, Maurice C, McNamara MG, Tieu MT, Lwin Z, Millar BA et al (2017) Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival. J Neurooncol 132(3):463\u2013471. https:\/\/doi.org\/10.1007\/s11060-017-2395-y","journal-title":"J Neurooncol"},{"issue":"11","key":"11525_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2217\/bmm-2021-0271","volume":"15","author":"V Haksoyler","year":"2021","unstructured":"Haksoyler V, A AB, Koseci T, Olgun P, Bayram E, Topkan E (2021) Neutrophil-to-lymphocyte ratio is prognostic in recurrent glioblastoma multiforme treated with bevacizumab plus Irinotecan. Biomark Med 15(11):851\u2013859. https:\/\/doi.org\/10.2217\/bmm-2021-0271","journal-title":"Biomark Med"},{"issue":"1","key":"11525_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0006-8993(92)90505-4","volume":"571","author":"T Nitta","year":"1992","unstructured":"Nitta T, Sato K, Allegretta M, Brocke S, Lim M, Mitchell DJ et al (1992) Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human Astrocytoma cell lines and in glioma specimens. Brain Res 571(1):19\u201325. https:\/\/doi.org\/10.1016\/0006-8993(92)90505-4","journal-title":"Brain Res"},{"key":"11525_CR40","doi-asserted-by":"publisher","first-page":"979748","DOI":"10.1155\/2013\/979748","volume":"2013","author":"R Albulescu","year":"2013","unstructured":"Albulescu R, Codrici E, Popescu ID, Mihai S, Necula LG, Petrescu D et al (2013) Cytokine patterns in brain tumour progression. Mediators Inflamm 2013:979748. https:\/\/doi.org\/10.1155\/2013\/979748","journal-title":"Mediators Inflamm"},{"issue":"22","key":"11525_CR41","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1158\/1078-0432.CCR-11-1107","volume":"17","author":"TR Sippel","year":"2011","unstructured":"Sippel TR, White J, Nag K, Tsvankin V, Klaassen M, Kleinschmidt-DeMasters BK et al (2011) Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res 17(22):6992\u20137002. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1107","journal-title":"Clin Cancer Res"},{"key":"11525_CR42","doi-asserted-by":"publisher","unstructured":"Han ZJ, Li YB, Yang LX, Cheng HJ, Liu X, Chen H (2021) Roles of the CXCL8-CXCR1\/2 axis in the tumor microenvironment and immunotherapy. Molecules 27(1) https:\/\/doi.org\/10.3390\/molecules27010137","DOI":"10.3390\/molecules27010137"},{"issue":"1","key":"11525_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40364-025-00849-0","volume":"13","author":"S Xiao","year":"2025","unstructured":"Xiao S, Zhang S, Sun K, Huang Q, Li Q, Hu C (2025) Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies. Biomark Res 13(1):134. https:\/\/doi.org\/10.1186\/s40364-025-00849-0","journal-title":"Biomark Res"},{"issue":"12","key":"11525_CR44","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.7150\/thno.111096","volume":"15","author":"J Zhang","year":"2025","unstructured":"Zhang J, Miao C, Zhang H (2025) Targeting neutrophil extracellular traps in cancer progression and metastasis. Theranostics 15(12):5846\u20135869. https:\/\/doi.org\/10.7150\/thno.111096","journal-title":"Theranostics"},{"issue":"1","key":"11525_CR45","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","volume":"11","author":"JV Gregory","year":"2020","unstructured":"Gregory JV, Kadiyala P, Doherty R, Cadena M, Habeel S, Ruoslahti E et al (2020) Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy. Nat Commun 11(1):5687. https:\/\/doi.org\/10.1038\/s41467-020-19225-7","journal-title":"Nat Commun"},{"key":"11525_CR46","doi-asserted-by":"publisher","first-page":"1180810","DOI":"10.3389\/fimmu.2023.1180810","volume":"14","author":"S Carnevale","year":"2023","unstructured":"Carnevale S, Di Ceglie I, Grieco G, Rigatelli A, Bonavita E, Jaillon S (2023) Neutrophil diversity in inflammation and cancer. Front Immunol 14:1180810. https:\/\/doi.org\/10.3389\/fimmu.2023.1180810","journal-title":"Front Immunol"},{"key":"11525_CR47","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3389\/fimmu.2019.02155","volume":"10","author":"P Lecot","year":"2019","unstructured":"Lecot P, Sarabi M, Pereira Abrantes M, Mussard J, Koenderman L, Caux C et al (2019) Neutrophil heterogeneity in cancer: from biology to therapies. Front Immunol 10:2155. https:\/\/doi.org\/10.3389\/fimmu.2019.02155","journal-title":"Front Immunol"},{"issue":"1","key":"11525_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","volume":"14","author":"S Xiong","year":"2021","unstructured":"Xiong S, Dong L, Cheng L (2021) Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol 14(1):173. https:\/\/doi.org\/10.1186\/s13045-021-01187-y","journal-title":"J Hematol Oncol"},{"issue":"1","key":"11525_CR49","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/s41467-022-32430-w","volume":"13","author":"S Coy","year":"2022","unstructured":"Coy S, Wang S, Stopka SA, Lin JR, Yapp C, Ritch CC et al (2022) Single cell Spatial analysis reveals the topology of Immunomodulatory purinergic signaling in glioblastoma. Nat Commun 13(1):4814. https:\/\/doi.org\/10.1038\/s41467-022-32430-w","journal-title":"Nat Commun"},{"issue":"10","key":"11525_CR50","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","volume":"187","author":"AC Greenwald","year":"2024","unstructured":"Greenwald AC, Darnell NG, Hoefflin R, Simkin D, Mount CW, Gonzalez Castro LN et al (2024) Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell 187(10):2485\u20132501 e26 https:\/\/doi.org\/10.1016\/j.cell.2024.03.029","journal-title":"Cell"},{"issue":"1","key":"11525_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41698-025-00830-y","volume":"9","author":"C Lemoine","year":"2025","unstructured":"Lemoine C, Da Veiga MA, Rogister B, Piette C, Neirinckx V (2025) An integrated perspective on single-cell and Spatial transcriptomic signatures in high-grade gliomas. NPJ Precis Oncol 9(1):44. https:\/\/doi.org\/10.1038\/s41698-025-00830-y","journal-title":"NPJ Precis Oncol"},{"issue":"4","key":"11525_CR52","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ et al (2019) An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178(4):835\u2013849 e21 https:\/\/doi.org\/10.1016\/j.cell.2019.06.024","journal-title":"Cell"},{"key":"11525_CR53","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.12688\/f1000research.126243.2","volume":"11","author":"A Perdyan","year":"2022","unstructured":"Perdyan A, Lawrynowicz U, Horbacz M, Kaminska B, Mieczkowski J (2022) Integration of single-cell RNA sequencing and Spatial transcriptomics to reveal the glioblastoma heterogeneity. F1000Res 11:1180. https:\/\/doi.org\/10.12688\/f1000research.126243.2","journal-title":"F1000Res"},{"issue":"6","key":"11525_CR54","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","volume":"40","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, Will P, Kueckelhaus J, Sun N, Joseph K, Salie H et al (2022) Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell 40(6):639\u2013655 e13 https:\/\/doi.org\/10.1016\/j.ccell.2022.05.009","journal-title":"Cancer Cell"},{"issue":"9","key":"11525_CR55","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/neuonc\/noaf113","volume":"27","author":"C Ruiz-Moreno","year":"2025","unstructured":"Ruiz-Moreno C, Salas SM, Samuelsson E, Minaeva M, Ibarra I, Grillo M et al (2025) Charting the single-cell and Spatial landscape of IDH-wild-type glioblastoma with GBmap. Neuro Oncol 27(9):2281\u20132295. https:\/\/doi.org\/10.1093\/neuonc\/noaf113","journal-title":"Neuro Oncol"},{"key":"11525_CR56","doi-asserted-by":"publisher","first-page":"1356611","DOI":"10.3389\/fgene.2024.1356611","volume":"15","author":"AL Johnson","year":"2024","unstructured":"Johnson AL, Lopez-Bertoni H (2024) Cellular diversity through space and time: adding new dimensions to GBM therapeutic development. Front Genet 15:1356611. https:\/\/doi.org\/10.3389\/fgene.2024.1356611","journal-title":"Front Genet"},{"issue":"5","key":"11525_CR57","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41588-025-02168-4","volume":"57","author":"A Spitzer","year":"2025","unstructured":"Spitzer A, Johnson KC, Nomura M, Garofano L, Nehar-Belaid D, Darnell NG et al (2025) Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics. Nat Genet 57(5):1168\u20131178. https:\/\/doi.org\/10.1038\/s41588-025-02168-4","journal-title":"Nat Genet"},{"issue":"7","key":"11525_CR58","doi-asserted-by":"publisher","first-page":"104570","DOI":"10.1016\/j.isci.2022.104570","volume":"25","author":"A Zomer","year":"2022","unstructured":"Zomer A, Croci D, Kowal J, van Gurp L, Joyce JA (2022) Multimodal imaging of the dynamic brain tumor microenvironment during glioblastoma progression and in response to treatment. iScience 25(7):104570. https:\/\/doi.org\/10.1016\/j.isci.2022.104570","journal-title":"iScience"},{"issue":"5","key":"11525_CR59","doi-asserted-by":"publisher","first-page":"e70733","DOI":"10.1002\/cam4.70733","volume":"14","author":"G Guo","year":"2025","unstructured":"Guo G, Zhang Z, Zhang J, Wang D, Xu S, Wu S et al (2025) Dynamic monitoring of Circulating tumor DNA to predict the risk of Non in situ recurrence of postoperative glioma: A prospective cohort study. Cancer Med 14(5):e70733. https:\/\/doi.org\/10.1002\/cam4.70733","journal-title":"Cancer Med"},{"key":"11525_CR60","doi-asserted-by":"publisher","unstructured":"Kim EL, Sorokin M, Kantelhardt SR, Kalasauskas D, Sprang B, Fauss J et al (2020) Intratumoral heterogeneity and longitudinal changes in gene expression predict differential drug sensitivity in newly diagnosed and recurrent glioblastoma. Cancers (Basel) 12(2) https:\/\/doi.org\/10.3390\/cancers12020520","DOI":"10.3390\/cancers12020520"},{"key":"11525_CR61","doi-asserted-by":"publisher","first-page":"117163","DOI":"10.1016\/j.jpba.2025.117163","volume":"267","author":"T Liu","year":"2026","unstructured":"Liu T, Kong Y, Ji X, Zheng C, Zhou C, Li Z et al (2026) Longitudinal profiling of cerebrospinal fluid N-glycome dynamics in glioblastoma patients treated with apatinib. J Pharm Biomed Anal 267:117163. https:\/\/doi.org\/10.1016\/j.jpba.2025.117163","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"11525_CR62","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13046-024-03231-4","volume":"43","author":"C Bastiancich","year":"2024","unstructured":"Bastiancich C, Snacel-Fazy E, Fernandez S, Robert S, Stacchini R, Plantureux L et al (2024) Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment. J Exp Clin Cancer Res 43(1):311. https:\/\/doi.org\/10.1186\/s13046-024-03231-4","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"11525_CR63","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.4103\/jcrt.jcrt_852_22","volume":"18","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lu F, Cai N, Tang L, Zhou Y, Li Y et al (2022) Analysis of antitumor immunity in mouse glioma microenvironment through intercellular communication. J Cancer Res Ther 18(5):1397\u20131408. https:\/\/doi.org\/10.4103\/jcrt.jcrt_852_22","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"11525_CR64","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-022-01298-0","volume":"15","author":"D Kreatsoulas","year":"2022","unstructured":"Kreatsoulas D, Bolyard C, Wu BX, Cam H, Giglio P, Li Z (2022) Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence. J Hematol Oncol 15(1):80. https:\/\/doi.org\/10.1186\/s13045-022-01298-0","journal-title":"J Hematol Oncol"},{"issue":"6","key":"11525_CR65","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.3390\/curroncol30060428","volume":"30","author":"AL Ren","year":"2023","unstructured":"Ren AL, Wu JY, Lee SY, Lim M (2023) Translational models in glioma immunotherapy research. Curr Oncol 30(6):5704\u20135718. https:\/\/doi.org\/10.3390\/curroncol30060428","journal-title":"Curr Oncol"},{"issue":"1","key":"11525_CR66","doi-asserted-by":"publisher","first-page":"29838","DOI":"10.1038\/s41598-025-15050-4","volume":"15","author":"C Huang","year":"2025","unstructured":"Huang C, Yu XB, Zhou YZ (2025) A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosis. Sci Rep 15(1):29838. https:\/\/doi.org\/10.1038\/s41598-025-15050-4","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11525-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11525-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11525-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:52:39Z","timestamp":1781632359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11525-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11525"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11525-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.K declares royalties (Thieme Medical publishing), consulting (Leica), and funding (JNJ\/Ethicon). All other authors declare no conflicts of interest. No funders had a role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. Ethics review was not required for this study due to review of publicly available, deidentified studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"349"}}